ArticleNanomaterials (Basel, Switzerland)2025
Low-Cost Versatile Microfluidic Platform for Bioorthogonal Click-Mediated Nanoassembly of Hybrid Nanosystems.
Article in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nanosystem-Mediated Phototherapy (PDT/PTT) - Chemodynamic Therapy for Synergistic Antitumor Therapy: Strategies and Advances.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
In recent years the global market of nanomedicine has experienced incredible growth owing to the advances in the field. This translation of the technique to the biomedical industry requires the development of production methods that deliver nanomedicines with a high degree of reproducibility between batches, combined with cost and time efficiency. The use of nanoparticles in medicine usually requires their surface functionalization to improve biocompatibility in addition to providing targeting capacities and/or stimuli-responsive behavior, among other interesting skills. Microfluidic technology has revolutionized the field both in nanomedicine synthesis and in preclinical evaluation. However, microfluidic-assisted synthetic procedures commonly require high-cost methods and equipment to fabricate the microreactors. The aim of this work is to present an ultra-low-cost microfluidic platform that permits the versatile modification of nanomaterials. To prove this approach, two different model nanoparticles with different natures: soft nanoparticles (liposomes) and rigid nanoparticles (mesoporous silica) have been decorated both with small molecules and with other nanoparticles, respectively, in order to evaluate the scope of this approach. The anchoring of the covalently attached elements has been performed using click chemistry, in compliance with the principles for further transfer to the drug industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.